Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Condition: Hepatitis B Virus Interventions: Biological: Human Serum Albumin/interferon alpha2b fusion protein; Biological: Pegasys Sponsor: Tianjin SinoBiotech Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials